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ABSTRACT 
 
The eleven-armed sea star, Coscinasterias muricata, is subject to human-induced 
stressors, such as invasive fishing activities, that can cause limb loss (amputation), and 
heavy metal discharge into their habitat. The well-being and survival of a keystone 
predator such as C. muricata has important ecological implications as their presence 
influences community structure in the marine environment.   
Understanding the stress physiology of an animal can provide insight into their overall 
health and survival. While the stress physiology of northern asteroid species (such as 
Asterias rubens) has been well documented, this has not been well studied with C. 
muricata. In this thesis, I was able to identify time-dependent changes in two 
physiological parameters (total coelomocyte count and dopamine levels in the coelomic 
fluid) in C. muricata subjected to amputation. There was a synchronous increase in 
both of these parameters 24 hours post amputation. 
Dopamine in the coelomic fluid was measured by using high performance liquid 
chromatography (HPLC). I adapted a pre-existing method involving pre-column 
derivatisation and fluorescent detection, which was initially developed for the detection 
of dopamine in porcine muscle. However, this method requires further development as 
it could not detect dopamine to the same sensitivity as previously reported HPLC 
methods using electrochemical detection. 
Lastly, the initial attempts at developing an in vitro cytotoxicity bioassay using C. 
muricata coelomocytes is described in detail. The initial aim of this experiment was to 
understand the effect of heavy metals on cellular parameters. However the experiment 
was hampered by unusually low cell counts in this species, which has not been 
previously reported. The knowledge gleaned from this study may provide the 
groundwork for future studies that use C. muricata coelomocytes for cytotoxicity testing 
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